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ABSTRACT
In this study, the cytocompatibility and early osteogenic characteristics of rat bone marrow cells
(RBMCs) on injectable calcium phosphate (CaP) cement (Calcibon) were investigated. In addition to
unmodified CaP cement discs, 2 other treatments were given to the discs: preincubation in MilliQ and
sintering at different temperatures. After primary culture, RBMCs were dropwise seeded on the discs
and cultured for 12 days. The samples were evaluated in terms of cell viability, morphology (live and dead
assays and scanning electron microscopy (SEM)), cell proliferation (deoxyribonucleic acid (DNA) ana-
lyses), early cell differentiation (alkaline phosphatase (ALP) activity), and physicochemical analyses (x-
ray diffraction (XRD)). The live and dead, DNA, and SEM results showed that Calcibon discs without
any additional treatment were not supporting osteoblast-like cells in vitro. There were fewer cells, and
cell layers were detached from the disc surface. Therefore, different preincubation periods and sintering
temperatures were evaluated to improve the cytocompatibility of the CaP cement. Preincubating discs in
MilliQ for periods of 1, 4, 8, and 12 weeks resulted in the hydrolysis of a-tri calcium phosphate (TCP)
into an apatite-like structure with some b-TCP, as shown with XRD, but the material was not cyto-
compatible. Sintering the discs between 8008C and 11008C resulted in conversion of a-TCP to b-TCP
with some hydroxyapatite and an increase in crystallinity. Eventually, the discs sintered at 11008C
achieved better cell attachment, more-abundant cell proliferation, and earlier differentiation than other
sintered (6008C, 8008C, and 10008C), preincubated, and unmodified specimens. On basis of our results,
we conclude that in vivo results with CaP-based cements do not guarantee in vitro applicability. Fur-
thermore, unmodified Calcibon is not cytocompatible in vitro, although preincubation of the material
results in a more-favorable cell response, sintering of the material at 11008C results in the best osteogenic
properties. In contrast to in vivo studies, the Calcibon CaP cement is not suitable as a scaffold for cell-
based tissue-engineering strategies.
INTRODUCTION
CURRENTLY, THE USE OF autologous and allogenous bonegrafts is the method of choice for the treatment of large
bone defects caused by trauma, disease, or tumor resection.
However, both of these methods are associated with signif-
icant clinical problems such as donor site morbidity and the
possible transfer of disease. In view of this, innovative bone-
engineering techniques have been introduced that include
the use of a suitable scaffold in combination with mesen-
chymal stem cells.1–8 Although the achieved results hold
promise, the final goal (the safe and reliable healing of large
bone defects) has not been accomplished. Current draw-
backs of cell-based bone engineering are the low yield of
cells with bone inducing capacities and the lack of stan-
dardized expansion and differentiation of progenitor cells.
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As a consequence, reproducibility and predictability in hu-
man patients is low. Several solutions have already been
suggested to solve this problem, such as the use of cell
selection,9–11 dynamic cell culture (flow perfusion sys-
tem),12–16 and encapsulation of cells in microspheres.17–20
The final cell population has to be incorporated in a scaf-
fold material that possesses intrinsic osteophilic properties.
For bone purposes, the ideal scaffold material is considered
to be bioactive, slowly biodegradable, moldable, and easy
to apply. The scaffold material must also have a certain
porosity, and the pores must have interconnectivity to allow
tissue ingrowth and stabilization. The recently developed
calcium phosphate (CaP) cements appear to fulfill these re-
quirements, because they support bone growth (osteocon-
ductive), are degradable because of osteoclastic remodeling,
are injectable, can incorporate microspheres, and can be
made micro- and macroporous to allow penetration of nu-
trients and clearance of waste.21–27 Unfortunately, the re-
sults obtained with the culturing of osteoblastic cells on
CaP cements are contradictory. This can be due to the
composition of the starting powder used for the preparation
of the CaP cement. For example, different CaP mixtures
have been used, such as tetra calcium phosphate, dicalcium
phosphate dehydrate, calcium pyrophosphate, tri calcium
phosphate (TCP), which transform into materials composed
of hydroxyapatite, carbonated apatite, and amorphous CaP
during setting. However, calcium and phosphate ions can
be released during this transformation process, which can
be harmful during cell culturing. The size or geometry of
the cement samples, manufacturing conditions, cell media
changes, and total cell-medium volume, among other
things, can enhance this effect. Evidently, no problems
have been observed for the in vivo behavior of these CaP
cement materials because the toxic products are sufficiently
transported away during the initial phases of wound heal-
ing. At the same time, this phenomenon can explain the
contradictory cell culture studies. For example, using the
CaP cement Calcibon (Merck Biomaterial GmbH, Darm-
stadt, Germany), Hempel et al. found a lower cell prolif-
eration and differentiation than with polystyrene cultures.
The CaP scaffolds in this study were preincubated in sim-
ulated body fluid for 4 days.28 In contrast to Hempel et al.,
Oreffo et al. and Knabe et al. reported lower cell prolif-
eration and greater cell differentiation on this material than
with polystyrene cultures. Oreffo et al. preincubated the
CaP scaffolds for 5 days in Ringer’s solution, and Knabe et
al. sterilized the scaffolds at 3008C for 3 h.28–30
Consequently, before the final use of CaP cement as scaf-
fold material for a cell-based tissue-engineering approach,
the cyto-compatibility of such a material has to be deter-
mined. In the current study, unmodified discs, together with
discs preincubated in MilliQ and discs sintered at different
temperatures, were used. These additional treatments can
create phase transformations of the CaP cement, which can
affect the cellular response.
MATERIALS AND METHODS
Substrates
Calcibon was used. The chemical composition of this
cement is 62.5% a-TCP, 26.8% dicalcium phosphate di-
hydrate, 8.9% calcium carbonate, and 1.8% precipitated
hydroxyapatite. An aqueous solution of 1% disodium hy-
drogen phosphate dodecahydrate is used as the liquid
component. The ideal liquid-to-powder ratio for clinical
applications has been shown to be 0.35 mL/g. After mixing,
the cement was immediately injected into a circular-shaped
mould to ensure a standardized shape of the discs (cylin-
ders of about 2.4 mm height and 6 mm diameter). The discs
were removed from the molds after the cement had set.
Histo-morphometrical analysis revealed that the total micro-
porosity (pores< 1 mm) of the cement was approximately
30% to 40%. In addition to the unmodified CaP cement
discs, samples were preincubated (1, 4, 8, and 12 weeks)
on a rotating plate in MilliQ, which was refreshed 3 times
a week or sintered in a furnace for 2 h at 6008C, 8008C,
10008C, or 11008C.
The chemical composition of the samples was evaluated
crushing the samples with a mortar until the discs were
reduced to powder and then analyzing them using x-ray
diffraction (XRD, Philips PW3710, Eindhoven, The Neth-
erlands). The positions and intensities of the XRD peaks
were used to identify the underlying structure (or phase) of
the various treatments of the specimens.
Cell isolation
Rat bone marrow cells (RBMCs) were isolated and cul-
tured using the method described by Maniatopoulos.31
RBMCs were obtained from femora of male Wistar rats
weighing between 120 g and 150 g. Femora were washed 3
times in culture medium minimal essential medium (MEM)
(Gibco BRL, Life Technologies B.V., Breda, The Nether-
lands) with 0.5 mg/mL gentamycin and 3 mg/mL Fungizone.
Epiphyses were cut off and diaphyses flushed out with
15 mL complete culture medium a-MEM supplemented
with 10% fetal calf serum (Gibco), 50 mg/mL ascorbic acid
(Sigma Chemical Co., St. Louis, MO), 50 mg/mL genta-
mycin, 10 mM sodium b-glycerophosphate (Sigma), and
108 M dexamethasone (Sigma). Cells were incubated in a
humidified atmosphere of 95% air, 5% carbon dioxide at
378C. The medium was changed 3 times a week.
After 7 days of primary culture, cells were detached using
trypsin/ethylenediaminetetraacetic acid (EDTA) (0.25% w/v
trypsin/0.02% EDTA). The cells were concentrated using
centrifugation at 1500 rpm for 5 min and resuspended in a
known amount of medium. Cells were counted using a
Coulter counter (Beckman Coulter, Mijdrecht, The Nether-
lands) and resuspended in complete culture medium. A cell
suspension of 50,000 cells per disc was used for the seeding
and culturing experiments.
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Cell viability
Live and dead viability assays (Molecular Probes, Leiden,
The Netherlands) (n¼ 2 for all culture periods), consisting
of washing with phosphate buffered saline (PBS), covering
with a mix of calcein AM (1.0 ml) and ethidium homodimer
(3.5ml), incubating 30 to 45 min at 378C, washing with PBS,
and examining under a fluorescence microscope, were per-
formed on days 0, 1, 2, 4, 8, and 12,. Metabolically active
cells were converting the calcein AM into green fluores-
cent calcein through intracellular esterases, where ethidium
homodimer entered dead cells through damaged membranes
to bind deoxyribonucleic acid (DNA). Green cells were vi-
able, and red cells were considered to be dead.
DNA analyses
DNA assays (Molecular Probes) (n¼ 6 for all culture pe-
riods) were performed on days 0, 1, 2, 4, 8, and 12. Culture
medium was removed, and discs were washed twice with
PBS. One mL of MilliQ was added to each sample. Cells
were harvested by placing the discs with inoculated cells in
a 1.5-mL tube. One mL of MilliQ was added to each sample.
Cell suspension was frozen to 808C, heated to 378C, fro-
zen to 808C again, and stored at 808C until usage.
A DNA standard curve was made using salmon testes
DNA. One hundred ml of sample or standard were added to
100 ml of Pico green working solution. The samples were
incubated for 5 min at room temperature in the dark. After
incubation, DNA was measured using a fluorescence mi-
croplate reader (Bio-Tek Instruments, Abcoude, The Neth-
erlands) with excitation filter 365 nm and emission filter
450 nm.
ALP activity
For the ALP assay (Sigma), the same samples from the
DNA assay were used. Eighty ml of sample and 20ml of buffer
solution (5 mM magnesium chloride, 0.5M 2-amino-2methyl-
1-propanol) were added in a 96-well plate. One hundred ml of
substrate solution (5mM p-nitrophenylphosphate) was added
to the well, and the plate was incubated for 1 h at 378C. The
reaction was stopped by adding 100ml of stop solution (0.3 M
sodium hydroxide). For the standard curve, serial dilutions of
4-nitrophenol were added to final concentrations of 0 to
25 nM. The plate was read in an enzyme-linked immuno-
sorbent assay reader (Bio-Tek Instruments) at 405 nm. ALP
activity results were normalized to ng of DNA.
Scanning electron microscopy
SEM analyses (n¼ 2 for all culture periods) were per-
formed on days 0, 1, 2, 4, 8, and 12. The samples were
washed twice with PBS. Fixation was carried out for 10 min
in 2% glutaraldehyde, and then substrates were washed
twice with 0.1 M sodium-cacodylate buffer (pH 7.4), de-
hydrated in a graded series of ethanol, and dried using tet-
ramethyl silane. The specimens were sputter-coated with
gold and examined and photographed using a Jeol 6310
SEM at an acceleration voltage of 10 kV. SEM was per-
formed at the Microscopic Imaging Center of the Nijmegen
Center for Molecular Life Sciences, The Netherlands.
Statistical analyses
Statistical analyses were performed using GraphPad In-
stat 3.05 software (GraphPad Software Inc., San Diego, CA)
using one-way analyses of variance with a Tukey multiple
comparison post test.
RESULTS
Unmodified Calcibon
The results of the XRD analyses (Fig. 1) demonstrated
that the unmodified CaP cement discs were mainly com-
posed of a-TCP. These samples caused the pH of the culture
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FIG. 1. X-ray diffraction (XRD) analyses of the calcium phos-
phate cement discs. The XRD powder patterns of (A) unmodified
and discs preincubated for 1, 4, 8, and 12 weeks and (B) un-
modified discs and discs sintered at 6008C, 8008C, 10008C, and
11008C are shown, respectively. (*¼ apatite; #¼ b-tri calcium
phosphate (TCP);þ¼ a-TCP).
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medium to decrease, indicated by the change of color from
red to yellowish. SEM images (Fig. 2A) revealed that cell
layers detached from the disc surface. This started at day 1
and was observed throughout the entire culture period. The
number of cells present on the surface also decreased over
time. At day 8, only a few viable cells were observed on the
disc surface with the live and dead assay (Fig. 3A). The re-
sults of the DNA analyses (Fig. 4) confirmed the results of
live and dead and SEM by showing reduced DNA content,
ending close to zero at day 12. Almost no ALP activity (Fig.
5) was measured during this culture period.
Preincubated Calcibon
The results of the XRD (Fig. 1A) demonstrated that
preincubation of the CaP cement discs in MilliQ resulted in
the hydrolysis of a-TCP into an apatite-like structure with
some b-TCP. These samples caused a decrease in pH of the
culture medium, indicated by the change of color from red
to yellowish. The duration (1, 4, 8, or 12 weeks) of prein-
cubation resulted in no changes in physico-chemical prop-
erties. Cell attachment and viability results were comparable
between the preincubation periods of 1, 4, 8, and 12 weeks
(data not shown). SEM examination (Fig. 2B) revealed that
cell layers were now only partially detaching from the disc
surface and that more cells were attached to the surface than
with the unmodified samples. This was already observed at
day 1 but also throughout the culture period. However, live
and dead assays (Fig. 3B) displayed a reduced cell number
after 8 days, although the cells were well spread on the sur-
face of the discs. DNA levels (Fig. 4) remained the same as
at the start of the experiment, but ALP activity (Fig. 5) was
close to zero.
Sintered Calcibon
The results of the XRD analyses (Fig. 1B) demonstrated
that the discs sintered at 6008C had the same chemical
properties as the unmodified samples. However, sintering at
8008C, 10008C, and 11008C resulted in conversion of a-
TCP into b-TCP with some hydroxyapatite and in an in-
crease of crystallinity (Fig. 1B). The 8008C samples (and to
a lesser extent the 10008C samples) caused a rapid increase
in pH of the culture medium, indicated by the change of
color from red to pink. The results of the live and dead and
SEM analyses showed that osteoblast-like cells were not
able to survive on the discs sintered at 8008C, whereas the
cells on the discs sintered at 10008C were viable and pro-
liferating. Nonetheless, the discs sintered at 11008C dem-
onstrated better cell attachment and viability throughout the
culturing period of 12 days than did those sintered at the
other temperatures (6008C, 8008C, 10008C) or preincubated
or unmodified discs. This was confirmed using SEM exam-
ination (Fig. 2C), which showed well-spread cell layers,
which were attached to the surface, and by the results of live
and dead analyses (Fig. 3C) revealing the presence of live
FIG. 2. Scanning electron microscopy of (A) unmodified discs, (B) discs preincubated for 1 week, and (C) discs sintered at 11008C
after day 1 of culture.
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cells over the complete surface area of the discs. DNA re-
sults (Fig. 4) showed that, from day 4, the amount of DNA
was significantly greater than in the preincubated and
unmodified samples; the difference was even greater after 8
and 12 days. In addition, ALP activity (Fig. 5) was observed
and showed a bell-shaped curve for osteoblast differentia-
tion, with peak activity at day 8. ALP activity at day 4 was
close to the peak activity at day 8, indicating an early dif-
ferentiation of the osteoblast-like cells. The increase in ALP
activity started ib the same day as cell seeding, also indi-
cating earlier differentiation of osteoblast-like cells.
DISCUSSION
The discrepancy in results of culturing cells on Calcibon
CaP cement was the underlying justification for the current
study, with specimens receiving different additional treat-
ments. Our results indicated that the unmodified specimens
were releasing calcium and phosphate ions in the medium,
creating an acidic environment for the osteoblast-like cells.
As a consequence, the seeded cells were slowly dying and
detached over time.
Preincubation of the CaP cement discs in MilliQ changed
the chemical properties of the material. The originally
present a-TCP was hydrolyzed within 1 week of preincu-
bation into an apatite-like structure with some b-TCP.
These preincubated samples showed a little bit better cell
viability than the unmodified CaP cement, but the material
was still suppressing cell proliferation and differentiation of
the osteoblast-like cells. The increase of acidity of the cell
culture medium, in combination with the dissolution and
re-precipitation of CaP phases of the discs, was hampering
cell proliferation and differentiation of the osteoblast-like
cells.32
On the other hand, XRD data showed that sintering
the CaP cement discs between 8008C and 11008C resulted
in conversion of a-TCP to b-TCP with some hydroxyapa-
tite and in an increase in crystallinity. The high sintering
temperature in which smaller crystallites grow to larger
FIG. 3. Live and dead assays of (A) unmodified, (B) discs preincubated for 1 week, and (C) discs sintered at 11008C after 8 days of
culture. Color images available online at www.liebertpub.com /ten.
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crystallites explains this increase in crystallinity. The discs
were sintered at a maximum temperature of 11008C; oth-
erwise the stable b-TCP would have been transformed into
a more-reactive a-TCP again.33 The b-TCP phase of the
sintered discs favors cell proliferation and differentiation
in vitro significantly, creating a good scaffold material to
support osteogenesis. Remarkably, the medium of the discs
sintered at 8008C rapidly turned basic, in which osteoblast-
like cells were unable to survive. The pH increase was also
observed in the medium of the discs sintered at 10008C but
to a lesser extent. Eventually, the discs sintered at 11008C
were the most physicochemically stable, resulting in better
cellular response of osteoblast-like cells than samples sin-
tered at other temperatures and preincubated and unmodi-
fied samples.34 Although ALP activity on day 0 of the discs
sintered at 11008C was low, the discs apparently stimulated
osteoblast differentiation already on the same day of cell
seeding. Therefore, the elevated ALP activity in all mea-
surements before day 8 can be explained. Furthermore, the
immediate use of complete culture medium was necessary
to direct the mesenchymal stem cells into the osteoblastic
lineage. Previous research has indicated that the use of min-
imal medium during primary culture and complete medium
during second culture would only delay differentiation of
the osteoblast-like cells.
As mentioned before, different results have been re-
ported regarding cell proliferation and cell differentiation of
osteoblasts-like cells when cultured on Calcibon.28–30,35 For
example, Hempel et al. described that the toxic effects of
unmodified CaP cement are due to physicochemically un-
stable discs and released phosphate and protons into the
culture medium, resulting in a decrease in pH and an uptake
of calcium by the specimens.30 The decrease in pH, which
was reported to affect cell attachment and behavior of the
osteoblast-like cells in vitro, was also observed in our exper-
iments with the unmodified and preincubated samples.36–38
Its changed color, which went from red to yellowish, illus-
trated the alteration of the pH in the culture medium. This
effect is the consequence of the presence of pH indicators
in the a-MEM solution. In contrast to Hempel et al.,Oreffo et
al. and Knabe et al. reported lower cell proliferation and
greater cell differentiation on Calcibon than with polystyrene
cultures, although they were still able to culture the cells for
an extended period.28,29 Our results showed fewer cells on
unmodified specimens over time. The alteration in pH and
extracellular concentrations of calcium and phosphate were
found to cause considerable stress for the osteoblast-like cells
and ultimately resulted in severely limited cell growth and
differentiation.30 It was reported that this could be avoided by
refreshing the medium daily, instead of every 2 to 3 days.
In this way, cell viability can be maintained and cell prolif-
eration and differentiation of the osteoblast-like cells im-
proved.39 In addition to the decrease in pH and the uptake of
calcium by the specimens, the negative effects on osteoblast-
like cells could be due to the particle size of the CaP cement.
Pioletti et al. described that CaP cement particles smaller than
10mm have an effect on the viability and proliferation of
osteoblast-like cells.40
Evidently, the observed acidity of Calcibon CaP cement
in in vitro cell culture experiments does not hamper the final
in vivo behavior of the material, because in vivo studies with
Calcibon21,24,41 describe excellent bone compatibility, as
characterized by the fast deposition of new bone on the ce-
ment surface, which proves that the material is osteocon-
ductive and suitable for clinical purposes. A reason for the
excellent in vivo behavior might be vascularization, which
provides a continuous flow around the inserted implant that
can elute the toxicity of the CaP cement. This emphasizes
that in vitro cell studies cannot be extrapolated implicitly to
the in vivo situation, which Rosengren et al., who found that
FIG. 4. Deoxyribonucleic acid (DNA) (Pico green) assay of
unmodified discs, discs preincubated for 1 week, and discs sintered
at 11008C until 12 days of culture. *Significant differences ( p<
0.05) between preincubated and unmodified discs; **a significant
difference ( p< 0.05) between discs sintered at 11008C and prein-
cubated and unmodified samples; ***a significant difference ( p<
0.05) between discs sintered at 11008C and unmodified samples.
FIG. 5. Alkaline phosphatase (ALP) activity assay of unmodi-
fied discs, discs preincubated for 1 week, and discs sintered at
11008C until 12 days of culture.
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an initially cytotoxic scaffold in vitro could, over the long
term, become biocompatible in vivo, described.42
CONCLUSIONS
On basis of our results, we conclude that in vivo results
with CaP-based cements do not guarantee their in vitro
applicability. Furthermore, unmodified Calcibon is not cyto-
compatible in vitro; although preincubation of the material
results in a more-favorable cell response, sintering of the
material at 11008C resulted in the best osteogenic proper-
ties. In contrast to in vivo studies, the Calcibon CaP cement
is not suitable as a scaffold for cell-based tissue-engineering
strategies.
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